Compass Therapeutics, Inc. (CMPX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 850K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 368K | 370K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -368K | -370K | 0 | 0 | 0 | 0 | 0 | 850K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 19.93M | 17.62M | 15.82M | 21.07M | 17.97M | 16.57M | 12.24M | 15.89M | 12.77M | 15.39M | 11.93M | 13.34M | 9.71M | 12.89M | 12.6M | 8.99M | 7.18M | 13M | 5.85M | 55.69M |
| OpEx % of Revenue | - | - | - | - | - | - | - | 1870% | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 6.56M | 4.32M | 2.99M | 4.65M | 4.91M | 3.54M | 3.63M | 4.72M | 3.25M | 2.97M | 3.1M | 3.11M | 3.07M | 2.96M | 2.81M | 3.13M | 2.77M | 3.43M | 2.7M | 2.17M |
| SG&A % of Revenue | - | - | - | - | - | - | - | 555.41% | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 13.38M | 13.67M | 12.83M | 16.41M | 13.05M | 13.04M | 8.61M | 11.17M | 9.52M | 12.43M | 8.83M | 10.22M | 6.64M | 9.93M | 9.79M | 5.86M | 4.42M | 9.57M | 3.15M | 2.9M |
| R&D % of Revenue | - | - | - | - | - | - | - | 1314.59% | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -370K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
| Operating Income | -20.3M | -17.99M | -15.82M | -21.07M | -17.97M | -16.57M | -12.24M | -15.04M | -12.77M | -15.39M | -11.93M | -13.34M | -9.71M | -12.89M | -12.6M | -8.99M | -7.18M | -13M | -5.85M | -55.69M |
| Operating Margin % | - | - | - | - | - | - | - | -1770% | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -12.99% | -8.54% | -29.23% | -40.02% | -40.69% | -7.67% | -2.62% | -12.81% | -31.5% | -19.44% | 5.33% | -48.4% | -35.21% | 0.87% | -115.2% | 83.86% | 2.14% | -63.53% | 34.67% | -998.4% |
| EBITDA | -19.93M | -17.62M | -15.8M | -20.7M | -17.6M | -16.21M | -11.77M | -14.58M | -12.31M | -15.23M | -11.46M | -12.86M | -9.23M | -12.4M | -12.11M | -8.49M | -6.75M | -12.61M | -5.45M | -55.28M |
| EBITDA Margin % | - | - | - | - | - | - | - | -1715.18% | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -13.23% | -8.66% | -34.18% | -41.98% | -43.02% | -6.45% | -2.74% | -13.35% | -33.34% | -22.8% | 5.38% | -51.51% | -36.8% | 1.59% | -122.3% | 84.64% | 2.58% | -83.19% | 36.1% | -1093.18% |
| D&A (Non-Cash Add-back) | 368K | 370K | 19K | 367K | 364K | 359K | 465K | 466K | 463K | 161K | 466K | 475K | 481K | 484K | 487K | 498K | 435K | 396K | 406K | 409K |
| EBIT | -20.3M | -17.99M | -14.26M | -21.07M | -17.97M | -16.57M | -12.24M | -15.04M | -12.77M | -15.39M | -11.93M | -13.34M | -9.71M | -11.59M | -12.6M | -8.99M | -7.18M | -12.96M | -5.9M | -55.68M |
| Net Interest Income | 1.98M | 2.27M | 1.56M | 1.19M | 0 | 1.59M | 1.76M | 1.97M | 0 | 1.98M | 1.96M | 2.06M | 0 | 0 | 0 | 0 | 0 | -35K | -77K | -102K |
| Interest Income | 1.98M | 2.27M | 1.56M | 1.19M | 0 | 1.59M | 1.76M | 1.97M | 0 | 1.98M | 1.96M | 2.06M | 0 | 1.29M | 623K | 424K | 20K | 4K | 1K | 9K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.29M | 623K | 424K | 20K | 39K | 78K | 111K |
| Other Income/Expense | 1.98M | 2.27M | 1.56M | 1.19M | 1.33M | 1.54M | 1.76M | 1.97M | 1.98M | 1.98M | 1.96M | 2.06M | 1.87M | 1.29M | 623K | 493K | 20K | 7K | -121K | -102K |
| Pretax Income | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M | -15.03M | -10.48M | -13.08M | -10.79M | -13.41M | -9.96M | -11.28M | -7.84M | -11.59M | -11.97M | -8.49M | -7.16M | -12.99M | -5.97M | -55.79M |
| Pretax Margin % | - | - | - | - | - | - | - | -1538.35% | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13K | 0 | 13K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.1% | 0% | -0.02% |
| Net Income | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M | -15.03M | -10.48M | -13.08M | -10.79M | -13.41M | -9.96M | -11.28M | -7.84M | -11.59M | -11.97M | -8.49M | -7.16M | -12.98M | -5.97M | -55.8M |
| Net Margin % | - | - | - | - | - | - | - | -1538.35% | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -10.12% | -4.54% | -36.05% | -52.04% | -54.19% | -12.06% | -5.19% | -15.94% | -37.64% | -15.71% | 16.79% | -32.78% | -9.42% | 10.68% | -100.42% | 84.78% | 3.5% | -54.7% | 34.7% | -904.21% |
| Net Income (Continuing) | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M | -15.03M | -10.48M | -13.08M | -10.79M | -13.41M | -9.96M | -11.28M | -7.84M | -11.59M | -11.97M | -8.49M | -7.16M | -12.98M | -5.97M | -55.8M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.10 | -0.09 | -0.10 | -0.14 | -0.12 | -0.11 | -0.08 | -0.10 | -0.08 | -0.11 | -0.08 | -0.09 | -0.05 | -0.10 | -0.11 | -0.08 | -0.07 | -0.25 | -0.10 | -1.07 |
| EPS Growth % | 16.67% | 22.73% | -31.23% | -47.37% | -50% | 0% | 4.75% | -5.56% | -69.49% | -12.36% | 27.27% | -13.49% | 33.33% | 60.84% | -10% | 92.59% | 49.43% | -78.57% | 33.33% | -872.73% |
| EPS (Basic) | -0.10 | -0.09 | -0.10 | -0.14 | -0.12 | -0.11 | -0.08 | -0.10 | -0.08 | -0.11 | -0.08 | -0.09 | -0.05 | -0.10 | -0.11 | -0.08 | -0.07 | -0.25 | -0.10 | -1.07 |
| Diluted Shares Outstanding | 186.4M | 184.84M | 138.28M | 138.28M | 138.24M | 136.63M | 137.59M | 137.59M | 136.61M | 127.67M | 127.42M | 126.73M | 126.38M | 105.19M | 101.01M | 100.95M | 100.86M | 51.91M | 61.69M | 51.91M |
| Basic Shares Outstanding | 186.4M | 184.84M | 138.28M | 138.28M | 138.24M | 136.63M | 137.59M | 137.59M | 136.61M | 127.67M | 127.42M | 126.73M | 126.38M | 105.19M | 101.01M | 100.95M | 100.86M | 51.91M | 61.69M | 51.91M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |